Alliance Global Partners Initiates Coverage On RenovoRx With Buy Rating, Announces Price Target of $4
BenzingaFeb 2 21:04
RenovoRx Analyst Ratings
BenzingaFeb 2 21:02
RenovoRx Analyst Ratings
BenzingaNov 16, 2023 00:28
Roth MKM Maintains Buy on RenovoRx, Lowers Price Target to $13
BenzingaAug 18, 2023 22:35
RenovoRx Analyst Ratings
BenzingaAug 18, 2023 22:34
Analysts Offer Insights on Healthcare Companies: Creative Medical Technology Holdings (CELZ), Boston Scientific (BSX) and RenovoRx (RNXT)
TipRanksJul 17, 2023 17:02
Maxim Group Keeps Their Buy Rating on RenovoRx (RNXT)
TipRanksMay 18, 2023 19:25
Maxim Group Remains a Buy on RenovoRx (RNXT)
TipRanksJan 20, 2023 03:30
No Data
No Data